569 related articles for article (PubMed ID: 18726886)
1. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy.
Kusamura S; Dominique E; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):247-52. PubMed ID: 18726886
[TBL] [Abstract][Full Text] [Related]
2. The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy.
Kusamura S; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):217-9. PubMed ID: 18726907
[TBL] [Abstract][Full Text] [Related]
3. Hyperthermic intraperitoneal chemotherapy: nomenclature and modalities of perfusion.
Glehen O; Cotte E; Kusamura S; Deraco M; Baratti D; Passot G; Beaujard AC; Noel GF
J Surg Oncol; 2008 Sep; 98(4):242-6. PubMed ID: 18726885
[TBL] [Abstract][Full Text] [Related]
4. The eligibility for local-regional treatment of peritoneal surface malignancy.
Verwaal VJ; Kusamura S; Baratti D; Deraco M
J Surg Oncol; 2008 Sep; 98(4):220-3. PubMed ID: 18726879
[TBL] [Abstract][Full Text] [Related]
5. Reported impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity.
Sugarbaker PH
Ann Surg Oncol; 2008 Jun; 15(6):1800-1; author reply 1802-3. PubMed ID: 18196342
[No Abstract] [Full Text] [Related]
6. The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus.
Baratti D; Kusamura S; Deraco M
J Surg Oncol; 2008 Sep; 98(4):258-62. PubMed ID: 18726888
[TBL] [Abstract][Full Text] [Related]
7. Technical aspects of cytoreductive surgery.
Kusamura S; O'Dwyer ST; Baratti D; Younan R; Deraco M
J Surg Oncol; 2008 Sep; 98(4):232-6. PubMed ID: 18726883
[TBL] [Abstract][Full Text] [Related]
8. [Peritoneal carcinomatosis of colorectal cancer: cytoreductive surgery and hyperthermic intraperitoneal chemotherapy].
Königsrainer I; Beckert S; Brücher B; Zieker D; Königsrainer A
Dtsch Med Wochenschr; 2011 Sep; 136(36):1811-4. PubMed ID: 21882140
[TBL] [Abstract][Full Text] [Related]
9. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy.
Younan R; Kusamura S; Baratti D; Cloutier AS; Deraco M
J Surg Oncol; 2008 Sep; 98(4):253-7. PubMed ID: 18726887
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trials for colorectal cancer peritoneal surface malignancy.
Avital I; Brücher BL; Nissan A; Stojadinovic A
Surg Oncol Clin N Am; 2012 Oct; 21(4):665-88. PubMed ID: 23021723
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer.
Helm CW; Bristow RE; Kusamura S; Baratti D; Deraco M
J Surg Oncol; 2008 Sep; 98(4):283-90. PubMed ID: 18726895
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].
Eveno C; Dagois S; Guillot E; Gornet JM; Pocard M
Bull Cancer; 2008 Jan; 95(1):141-5. PubMed ID: 18230580
[TBL] [Abstract][Full Text] [Related]
13. Current status and future directions of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of ovarian cancer.
Helm CW
Surg Oncol Clin N Am; 2012 Oct; 21(4):645-63. PubMed ID: 23021722
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care.
McQuellon R; Gavazzi C; Piso P; Swain D; Levine E
J Surg Oncol; 2008 Sep; 98(4):300-5. PubMed ID: 18726903
[TBL] [Abstract][Full Text] [Related]
15. Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment.
Valle M; Federici O; Garofalo A
Surg Oncol Clin N Am; 2012 Oct; 21(4):515-31. PubMed ID: 23021713
[TBL] [Abstract][Full Text] [Related]
16. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.
Helm CW
Oncologist; 2009 Jul; 14(7):683-94. PubMed ID: 19608639
[TBL] [Abstract][Full Text] [Related]
17. Anesthesia considerations during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Rothfield KP; Crowley K
Surg Oncol Clin N Am; 2012 Oct; 21(4):533-41. PubMed ID: 23021714
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.
González-Moreno S; González-Bayón L; Ortega-Pérez G
Surg Oncol Clin N Am; 2012 Oct; 21(4):543-57. PubMed ID: 23021715
[TBL] [Abstract][Full Text] [Related]
19. Consensus statement on peritoneal mesothelioma.
Deraco M; Bartlett D; Kusamura S; Baratti D
J Surg Oncol; 2008 Sep; 98(4):268-72. PubMed ID: 18726890
[TBL] [Abstract][Full Text] [Related]
20. Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement.
Yan TD; Morris DL; Shigeki K; Dario B; Marcello D
J Surg Oncol; 2008 Sep; 98(4):224-7. PubMed ID: 18726881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
